1. Background
2. Objectives
3. Methods
4. Results
| Characteristics | Adolescent Age Group, (Group A) | Advanced Age Group, (Group B) | Control Group, (Group C) | |||
|---|---|---|---|---|---|---|
| Mean Age | Range | Mean Age | Range | Mean Age | Range | |
| Age, y | (17.2 ± 3.1 ) | (16 - 20) | (38.2 ± 2.4) | (35 - 42) | (28.2 ± 3.2) | (21 - 36) |
| Abortion | Number | Percent | Number | Percent | Number | Percent |
| Total | 129 | 39.5 | 198 | 60.1 | 472 | 11.6 |
| A1 | 88 | 68 | 65 | 66 | 318 | 67 |
| > A2 | 41 | 32 | 133 | 34 | 144 | 33 |
| Parity | Number | Percent | Number | Percent | Number | Percent |
| P1 | 207 | 63 | 83 | 25 | 1635 | 40.2 |
| > P2 | 119 | 37 | 246 | 75 | 2430 | 59.7 |
| Parameter | Group A (326) | Group B (329) | Group C (4065) |
|---|---|---|---|
| PE | 80 ( 24) | 38 (11) | 304 (7.4) |
| Eclampsia | 38 (11.6) | 6 (1.8) | 98 (2.4) |
| Gestational diabetes | 4 (1.6) | 11 (3. 2) | 12 (3.6) |
| Anemia | 106 (31.6) | 79 (23.9) | 248 (6) |
| Cholestasis | 4 (1.6) | 6 (1.8) | 67 (1.6) |
| Twins | 17 (5.2) | 7 (2.1) | 78 (1.9) |
| Preterm | 72 (22) | 264 (6.4) | 16 (4.8) |
| PROM | 33 (13.1) | 13 (3.9) | 116 (3.8) |
| Placenta Previa | 12 (3.6) | 17 (3.4) | 139 (3.4) |
| Placental Abruption | 5 (1.5) | 2 (0.6) | 42 (1) |
| IUGR | 21 (6.4) | 6 (1.8) | 146 (3.6) |
| IUD | 49 (15) | 26 (7.9) | 281 (6.9) |
| Congenital anomaly | 6 (1.8) | 9 (2.9 ) | 36 (1.1) |
| Obstructed labor | 3 (0.9) | 11 (3.3) | 66 (1.6) |
| Fibroid | 0 | 1 (0.3) | 10(1.2) |
| Rheumatic heart disease | 8 (2.4) | 4 (1.2) | 44 (1.1) |
| Jaundice | 8 (2.4) | 3 (0.9) | 66(1.6) |
| Hypothyroidism | 1 (0.3) | 5 (1.5) | 50 (1.2) |
| Deliveries Vaginal | 178 (54) | 131 (40) | 2296 (56) |
| LSCS | 148 (46) | 198 (60) | 1796 (44) |
| Preterm | 105 (32) | 30 (8.8) | 407(9.3) |
| IUGR | 279 (85.5) | 114 (34) | 1032 (25) |
Abbreviations: IUGR, intrauterine growth restriction; IUD, intrauterine death; LSCS, lower segment cesarean section; PE, preeclampsia; PROM, premature rupture of membranes; RHD, rheumatic heart disease.
aValues are expressed as No. (%).
| Variable | A Versus C | B Versus C | ||
|---|---|---|---|---|
| OR (CI) | P Value | OR (CI) | P Value | |
| Abortion | 5.4 (4.2 - 6.9) | < 0.001 | 12.4 (9.7 - 15.9) | < 0.001 |
| PE | 4 (3.0 - 5.3) | < 0.0001 | 1.6 (1.1 - 2.3 ) | < 0.008 |
| Eclampsia | 3.9 (2.6 - 6 ) | < 0.0001 | 0.75 (0.3 - 1.79 ) | 0.5 |
| Gestatinal diabetes mellitus | 0.75 (0.12 - 0.7) | 1 | 1.1 (03 - 3.8) | 0.7 |
| Anemia | 13.6 (10 - 18.3) | < 0.001 | 4.86 (3.6 - 6.5) | < 0.001 |
| Cholestasis | 0.3 (0.1 - 2.2) | 0.3 | 1.3 (0.4 - 3.9) | 0.5 |
| Twins | 2.8 (1.6 - 4.9) | < 0.001 | 1.1 (0.4 - 2.5) | 0.8 |
| Preterm | 4.1 (3 - 5.5) | < 0.001 | 0.7 (0.4 - 1.2) | 0.2 |
| PROM | 3 (1.9 - 4.7) | < 0.001 | 2 (1.2 - 3.4) | < 0.006 |
| Placenta Previa | 1.1 (0.5 - 2) | 0.9 | 1.5 (0.9 - 2.6) | 0.1 |
| Placental abruption | 1.5 (0.5 - 3.9) | 0.4 | 0.6 (0.1 - 2.5) | 0.7 |
| IUGR | 1.8 (1.1 - 3) | 0.01 | 0.5 (0.2 - 1.1) | 0.12 |
| IUD | 2.4 (1.7 - 3.3) | < 0.001 | 1.19 (0.7 - 1.8) | 0.5 |
| Congenital Anomaly | 2.1 (0.8 - 5.2) | 0.1 | 0.7 (0.1 - 2.9) | 1 |
| Obstructed Labor | 1.1 (0.3 - 4) | 0.7 | 1.9 (0.6 - 5.2) | 0.2 |
| RHD | 2.3 (0.1 - 5.1) | 0.05 | 1.1 (99.3 - 3.2) | 0.7 |
| Jaundice | 1.5 (0.6 - 3.3) | 0.3 | 0.5 (0.1 - 1.8) | 0.4 |
| Hypothyroidism | 0.2 (0.01 - 1.6) | 0.1 | 1.2 (1.4 - 3.2) | 0.6 |
| LSCS | 1.1 (0.8 - 1.3) | 0.5 | 1.2 (1.5 - 2.5) | < 0.001 |
| Preterm neonate | 4.2 (3.3 - 5.5) | < 0.001 | 0.9 (0.6 - 1.35) | 0.67 |
| Small for Gestational age | 17 (12.5 - 24) | < 0.001 | 1.6 (1.2 - 2) | < 0.001 |
Abbreviatins: IUGR, intrauterine growth restriction; IUD, intrauterine death; PE, preeclampsia, PROM, premature rupture of membranes; RHD, rheumatic heart disease; LSCS, lower segment caesarean section.